Screener
Rapport Therapeutics, Inc. RAPP Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s net income?
- Rapport Therapeutics, Inc. (RAPP) reported net income of -$56.62M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s net income changed year-over-year?
- Rapport Therapeutics, Inc.'s net income decreased by 111.8% year-over-year, from -$26.73M to -$56.62M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s net income?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s net income has grown at a 79.0% compound annual growth rate (CAGR), from -$34.79M to -$111.48M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Rapport Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude